Publication

Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks

An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer

AI Pathology Starts Moving Toward Treatment Selection

Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis

AI Multiomics Moves Into the Trial Stratification Layer

The AMR Pipeline Is Too Thin for the Threat Ahead
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
